filgrastim

Poland

Drugs containing this active substance

  • NEUPOGEN

    Neupogen is used to increase the number of white blood cells (neutropenia) following chemotherapy or bone marrow transplantation to prevent infections. It may also be used in individuals with severe chronic neutropenia, in patients with advanced HIV infection, and before high-dose chemotherapy to stimulate the bone marrow to produce stem cells.

    Form: solution for injection

    Active substance Dosage
    filgrastim No input provided

    ATC: L03AA02

    Manufacturer: Amgen Europe B.V. Amgen NV Amgen Technology (Ireland) Unlimited Company

  • NEUPOGEN

    The medicine is used to increase the number of white blood cells (neutrophils) in the body. It is used, among other things, after chemotherapy or bone marrow transplantation to prevent infections, in cases of severe chronic neutropenia, and in patients with advanced HIV infection.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    filgrastim No input provided

    ATC: L03AA02

    Manufacturer: Amgen Europe B.V. Amgen NV Amgen Technology (Ireland) Unlimited Company

  • NEUPOGEN

    The medicine is used to increase the number of white blood cells (neutropenia) after chemotherapy or bone marrow transplantation, in individuals with severe chronic neutropenia, and in patients with advanced HIV infection. It may also be used before high-dose chemotherapy to stimulate the bone marrow to produce stem cells.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    filgrastim No input provided

    ATC: L03AA02

    Manufacturer: Amgen Europe B.V. Amgen NV Amgen Technology (Ireland) Unlimited Company